Abstract:Objective To ascertain the short-term and long-term outcomes of expanding criteria for resectability of colorectal liver metastases(CRLM) from Chinese Guidelines for the Diagnosis and Comprehensive Treatment of Hepatic Metastasis of Colorectal Cancer(Version 2010).Methods The data of 530 consecutive CRLM patients underwent hepatectomy between 2000 and 2010 in Zhongshan Hospital of Fudan University were analyzed retrospectively. Patients were divided into two groups according to different resectability criterias(group I: 2000-2004; group II: 2005-2010).Mortality, morbidity and survival rates were evaluated.Results After the expansion of resectability criteria,hepatectomy rate increased from 25.1% to 35.1%(P<0.05). Patients in group II presented with higher preoperative serum CEA and CA19-9 levels. Although perioperative mortality(2.2% in group I and 0.9% in group II) and morbidity(20.9%in group I and 29.8% in group II) were observed with no significant difference between two groups. But there was a trend toward a higher morbidity was observed in group II. In addition, there was no significant difference in recurrence rate(27.5% in group I and 36.7% in group II) or overall survival(43.7 months in group I and 55.7 months in group II; 5-year survival, 43% and 49%).Conclusion The favorable short-term and long-term outcomes justify an expansion of the criteria for respectability in Chinese Guidelines for the Diagnosis and Comprehensive Treatment of Hepatic Metastasis of Colorectal Cancer(Version 2010).

Rethinking the standardization and advances in diagnosis and treatment of colorectal liver metastases from ESMO Clinical Practice Guidelines for Metastatic Colorectal Cancer

[Standardized Diagnosis and Treatment of Colorectal Liver Metastasis from the Perspective of Evidence-Based Medicine].

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)

Standardized treatment of colorectal liver metastases

Chinese Guidelines for the Diagnosis and Comprehensive Treatment of Colorectal Liver Metastases (V. 2023)

China Guideline for Diagnosis and Comprehensive Treatment of Colorectal Liver Metastases (version 2018)

[Interpretation of Guidelines for the Diagnosis and Comprehensive Treatment of Colorectal Cancer Liver Metastases in China(v2013)].

Shanghai International Consensus on Diagnosis and Comprehensive Treatment of Colorectal Liver Metastases (version 2019)

Advances in molecular biology and clinical practice of rectal liver metastases

Perioperative Treatment Strategy for Colorectal Liver Metastases

Treatment progression in colorectal cancer liver metastasis

Multidisciplinary approach of liver metastases from colorectal cancer

Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer

Recent Advances in the Comprehensive Treatment of Colorectal Liver Metastases

Expert Consensus on Maintenance Treatment for Metastatic Colorectal Cancer in China.

Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006

Advances in Treatment of Liver Metastasis of Colorectal Cancer

Recent advances in colorectal cancer liver metastases

Advance of chemotherapy and targeted therapy in colorectal liver metastases

Principle and progress of surgery for colorectal cancer

Colorectal liver metastasis: molecular mechanism and interventional therapy